Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group
暂无分享,去创建一个
E. Bröcker | R. MacKie | U. Kleeberg | P. Rümke | A. Planting | M. Lentz | F. Lejeune | J. Bierhorst